Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 3183 (MIR3183) is a small, endogenously expressed, non-coding RNA molecule of the microRNA class in humans. MicroRNAs mediate post-transcriptional gene silencing by binding to complementary sequences in target mRNAs, typically resulting in translational repression or target degradation. Like other miRNAs, MIR3183 is produced from a precursor transcript by processing through the Drosha and Dicer RNase complexes, eventually becoming part of a silencing effector complex that regulates gene expression[1]. While the functions of many microRNAs in biological pathways and diseases such as cancer, immune response, and cell cycle control are well established, the specific targets and physiological roles of MIR3183 have not yet been well characterized in the published literature[1][3][4][5]. If you are seeking therapeutic relevance, current evidence does not support MIR3183 as a direct druggable target or an established biomarker, but research in microRNA biology is rapidly evolving, and new associations may be described as expression profiling and functional studies advance[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 3183 (MIR3183).